Synthesis and evaluation of antiproliferative activity of a geldanamycin-Herceptin™ immunoconjugate

被引:14
作者
Mandler, R
Dadachova, E
Brechbiel, JK
Waldmann, TA
Brechbiel, MW [1 ]
机构
[1] NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20982 USA
[2] NCI, Metab Branch, NIH, Bethesda, MD 20982 USA
关键词
D O I
10.1016/S0960-894X(00)00155-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Geldanamycin was modified with 1,4-diaminobutane to introduce a primary amine that was subsequently employed to provide a maleimide for protein linkage. Monoclonal antibody Herceptin(TM) was then derivatized to generate thiol groups that reacted with the maleimide derivative to produce the immunoconjugate. The product showed antiproliferative activity greater than native Herceptin(TM). (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1025 / 1028
页数:4
相关论文
共 29 条
[1]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[2]   Induction of multiple anti-c-erB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment [J].
Clark, JI ;
Alpaugh, RK ;
vonMehren, M ;
Schultz, J ;
Gralow, JR ;
Cheever, MA ;
Ring, DB ;
Weiner, LM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (05) :265-272
[3]   Clinical experience with CD64-directed immunotherapy. An overview [J].
Curnow, RT .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 45 (3-4) :210-215
[4]   GELDANAMYCIN, A NEW ANTIBIOTIC [J].
DEBOER, C ;
MEULMAN, PA ;
WNUK, RJ ;
PETERSON, DH .
JOURNAL OF ANTIBIOTICS, 1970, 23 (09) :442-&
[5]  
GROSSBARD ML, 1992, BLOOD, V80, P863
[6]  
Hartmann F, 1997, INT J CANCER, V70, P221, DOI 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO
[7]  
2-L
[8]  
Ho D, COMMUNICATION
[9]   Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy [J].
Hung, MC ;
Chang, JYJ ;
Xing, XM .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 30 (1-3) :219-227
[10]   THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER [J].
HYNES, NE ;
STERN, DF .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3) :165-184